Sort by
Refine Your Search
-
program. This includes the opportunity to participate in teaching activities for students in the new Bioengineering PhD program or undergraduate members of the iGEM Synthetic Biology team. The facility
-
two postdoctoral fellowships to our 2026-27 cohort. PIIRS seeks recent PhDs in the Social Sciences who have demonstrated exceptional scholarship, congruent with the Institute's intellectual focus
-
- August 2027). Verification of employment will be requested prior to approval by the Office of the Dean of the Faculty. PhD or equivalent doctoral degree required. Applicants must apply online and submit a
-
of relevant physical, chemical, computational, and engineering technologies and exploration of relevant biological factors including diet and the microbiome. Applicants are expected to hold a PhD or MD
-
seek applicants with demonstrated excellence in research and a commitment to teaching and mentoring. Applicants are expected to have earned their PhD by September 2026. Interested applicants should apply
-
physical, chemical, computational, and engineering technologies and exploration of relevant biological factors including diet and the microbiome. Applicants are expected to hold a PhD or MD, optionally with
-
diet and the microbiome. Applicants are expected to hold a PhD or MD, optionally with relevant additional research experience (industrial, postdoctoral, or as a faculty member), and a strong track
-
public-facing museum and will communicate effectively with both scholarly and broad audiences. A PhD in art history, anthropology, or a related field is required for this position. Applicants must have
-
program. This includes the opportunity to participate in teaching activities for students in the new Bioengineering PhD program or undergraduate members of the iGEM Synthetic Biology team. The facility
-
-2 years experience from PhD, MD, or clinical training). The program centers on cancer metabolism, broadly defined to include technology development, computation, biological studies, drug development